Treatment of ADHD in prison inmates

 

Dr Ylva Ginsberg and colleagues recently conducted a study to test the effectiveness of methylphenidate as a treatment for ADHD in prison inmates. Here, Dr Ginsberg discusses her findings with Dr Ovais Badat, and reviews how the research can influence future treatment in prison populations.


 

Date published: 13 March 2012

Presenter: Dr Ovais Badat

Interviewee: Dr Ylva Ginsberg

Audio running time: 15 minutes

Credits: 0.5

 

Learning outcomes

 

By the end of this podcast, we hope you will have gained an understanding of:

 

  • the prevalence of ADHD in prison inmates

 

  • the background of and reasons for this particular study

 

  • the effectiveness of osmotic-release oral system (OROS) methylphenidate as a treatment for male long-term prison inmates with ADHD

 

  • how this study has altered practice in the Swedish prison and probation service

 

  • how the findings can help with research and clinical practice in the future.

 

Take the module test and gain CPD certification

 

Please note: This podcast was recorded in 2012. Please be aware that some of the material covered and/or guidance may have changed.
Having problems downloading or playing the podcast file? View our troubleshooting page.

 

If you like this podcast, you may also be interested in the following:

 

Assessing and communicating violence risk by Dr Mike Doyle

 

Neurobiology of ADHD by Dr Katia Rubia

 

Rehabilitation psychiatry: principles and practice by Dr Frank Holloway

© 2018 Royal College of Psychiatrists